PARADISE-MI findings show sacubitril/valsartan didn’t significantly ⬇️ rate of #CVD death, #HeartFailure hospitalization or outpatient HF requiring treatment following #cvMI compared w/ ramipril. Researchers said safety/tolerability was comparable. https://t.co/toDZm0MND2 #ACC21